인슐린 전달 기기 시장 규모, 점유율, 성장 분석 : 제품 유형별, 당뇨병 유형별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Insulin Delivery Devices Market size was valued at USD 18.02 Billion in 2024 and is poised to grow from USD 19.44 Billion in 2025 to USD 35.72 Billion by 2033, growing at a CAGR of 7.9% during the forecast period (2026-2033).

The global market for insulin delivery devices is experiencing robust growth, primarily fueled by the rising prevalence of diabetes worldwide. This surge in demand is leading to the development of more advanced, user-friendly diabetes management systems. The integration of digital technologies is expected to further propel market expansion, particularly through innovations like Continuous Glucose Monitoring (CGM) systems, which enable insulin delivery devices to automatically adjust dosages in real-time based on continuous glucose readings. Additionally, wearable and patch insulin pumps are gaining traction as discreet and convenient solutions for insulin administration. The advancement of technologies, including promising new applications for patch insulin systems, signifies a significant evolution in the capabilities and effectiveness of insulin delivery methods, catering to the needs of patients.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insulin Delivery Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Delivery Devices Market Segments Analysis

Global Insulin Delivery Devices Market is segmented by Product Type, Diabetes Type, End-User and region. Based on Product Type, the market is segmented into Insulin Pens, Insulin Pumps (Tethered), Insulin Pumps (Tubeless / Patch), Insulin Syringes & Needles and Smart Insulin Delivery Devices. Based on Diabetes Type, the market is segmented into Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes and Other Special Populations. Based on End-User, the market is segmented into Home Care / Self-administration, Hospitals & Clinics and Specialized Diabetes Care Centres. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Insulin Delivery Devices Market

The Global Insulin Delivery Devices market is experiencing significant growth due to the rise of interoperable ecosystems that integrate insulin delivery systems with continuous glucose monitors (CGMs), smartphone applications, smart pens, and connected pumps. This connectivity enhances dosage precision, fosters patient adherence, and enables remote monitoring by healthcare providers, which can lead to a reduction in hypoglycemic events and decreased hospital visits. As reimbursement for telehealth services and digital diabetes management programs continues to expand, more connected devices are being introduced into home care and outpatient settings. This trend not only boosts clinician confidence but also increases patient comfort and engagement in their diabetes management.

Restraints in the Global Insulin Delivery Devices Market

The Global Insulin Delivery Devices market faces significant challenges due to the elevated costs associated with these devices and their necessary consumables, especially for automated pumps and integrated systems, which creates barriers for price-sensitive markets. Variations in reimbursement mechanisms across regions further complicate the situation, often leading to decreased adoption when coverage is limited. Moreover, many payers exhibit hesitance in endorsing advanced technologies such as patch pumps and closed-loop systems, which hinders their market penetration. To enhance accessibility and reduce expenses for patients, manufacturers must demonstrate that their products are justifiable and attainable within the healthcare landscape.

Market Trends of the Global Insulin Delivery Devices Market

The Global Insulin Delivery Devices market is witnessing a notable trend towards the adoption of smaller, tubeless patch pumps, which are transforming insulin administration into a more convenient and user-friendly experience. These innovative devices are designed to enhance user comfort and compliance by eliminating cumbersome tubing while integrating advanced smartphone controls and automated algorithms. This technological evolution is appealing not only to existing users but also to those who have been hesitant to embrace traditional insulin pumps. As healthcare professionals continue to endorse these systems for their potential to improve patient outcomes, the demand for such devices is anticipated to surge, reflecting a broader shift towards more efficient diabetes management solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Insulin Delivery Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Insulin Pens
• Insulin Pumps (Tethered)
• Insulin Pumps (Tubeless / Patch)
• Insulin Syringes & Needles
• Smart Insulin Delivery Devices

Global Insulin Delivery Devices Market Size by Diabetes Type & CAGR (2026-2033)

• Market Overview
• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes
• Other Special Populations

Global Insulin Delivery Devices Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Home Care / Self-administration
• Hospitals & Clinics
• Specialized Diabetes Care Centres

Global Insulin Delivery Devices Market Size & CAGR (2026-2033)

• North America (Product Type, Diabetes Type, End-User)
  • US
  • Canada
• Europe (Product Type, Diabetes Type, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Diabetes Type, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Diabetes Type, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Diabetes Type, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Owen Mumford Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Diabetes Care Division)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (Diabetes Care)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (Diabetes Solutions)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom, Inc. (Integrated pump solutions)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care Holdings AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SOOIL Development Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nippon Boehringer Ingelheim Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AgaMatrix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omron Healthcare Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations